Latest CTSO reports update at 2024-05-09: 2024-Q12023-Q42023-Q1
Cytosorbents Corporation logo
Cytosorbents Corporation CTSO
$ 0.81 -7.1%

Cytosorbents Corporation Balance Sheet 2011-2024 | CTSO

Annual Balance Sheet Cytosorbents Corporation

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-17 M -38.3 M - 2.82 M -12.4 M -7.33 M -334 K -5.32 M -3.61 M -539 K -803 K -616 K

Long Term Debt

5 M 13.3 M - 13.4 M 9.27 M 5.99 M 4.08 M - - - - 276 K

Long Term Debt Current

109 K 571 K 447 K 428 K 667 K 4 M 833 K - - - - -

Total Non Current Liabilities

- - - 14 M 9.27 M 5.99 M 4.08 M - - 15.2 M 12.9 M 276 K

Total Current Liabilities

9.71 M 13.7 M 10.2 M 9.94 M 6.54 M 7.85 M 6.09 M 3.04 M 4.51 M 3.06 M 2.08 M 1.53 M

Total Liabilities

27.9 M 26.9 M 10.7 M 24 M 15.8 M 13.8 M 10.2 M 3.04 M 4.51 M 18.3 M 15 M 1.8 M

Deferred Revenue

1.52 M 1.95 M 1.03 M 158 K - 14.7 K - 30 K 30.8 K 272 K - -

Retained Earnings

-254 M -221 M -197 M -189 M -170 M -152 M -144 M -133 M -124 M -106 M -98.7 M -92.6 M

Total Assets

63.2 M 89.5 M 90 M 27.4 M 32.7 M 24.1 M 9.69 M 11.3 M 8.47 M 4.05 M 3.34 M 2.12 M

Cash and Cash Equivalents

22.1 M 52.1 M 71.4 M 12.2 M 22.4 M 17.3 M 5.25 M 5.32 M 3.61 M 2.18 M 1.73 M 1.19 M

Book Value

35.4 M 62.6 M 79.2 M 3.42 M 16.9 M 10.3 M -474 K 8.21 M 3.96 M -14.3 M -11.6 M 318 K

Total Shareholders Equity

35.4 M 62.6 M 79.2 M 3.42 M 16.9 M 10.3 M 1.34 M 9.85 M 3.96 M -14.3 M -11.6 M -10.1 M

All numbers in USD currency

Quarterly Balance Sheet Cytosorbents Corporation

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

1.93 M 2.54 M 4.2 M 5.02 M 5.01 M 5 M 13 M - 13.2 M 13.3 M 13.4 M 13 M 461 K - 5.99 M 8.46 M 10.9 M 13.4 M 13.4 M 13.4 M 13.4 M 9.27 M 9.27 M 9.27 M 9.27 M 5.99 M 5.99 M 5.99 M 5.99 M 4.08 M 4.08 M 4.08 M 4.08 M - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 276 K 276 K 276 K 276 K

Total Liabilities

28.1 M 30 M 29.1 M 28.4 M 28.5 M 27.9 M 23.1 M - 27.8 M 26.9 M 24.5 M 23.8 M 10.2 M 10.7 M 10.7 M 10.7 M 10.7 M 24 M 24 M 24 M 24 M 17.3 M 17.3 M 17.3 M 17.3 M 13.8 M 13.8 M 13.8 M 13.8 M 8.36 M 8.36 M 10.2 M 10.2 M 3.04 M 3.04 M 3.04 M - - - - - 3.06 M 3.07 M 2.1 M 993 K 2.08 M 2.08 M 2.08 M 2.08 M 1.8 M 1.8 M 1.8 M 1.8 M

Deferred Revenue

- - - - - - - - - 1.95 M - - - 728 K - - 32.3 K - - - - 42.2 K 42.2 K 42.2 K 42.2 K 30.4 K 30.4 K 30.4 K 30.4 K - - - - - - - - 833 833 833 833 272 K 272 K 272 K 272 K - - - - - - - -

Retained Earnings

-289 M -283 M -277 M -267 M -261 M -254 M -253 M - -230 M -221 M -212 M -205 M -201 M -197 M -197 M -197 M -197 M -189 M -189 M -189 M -189 M -170 M -170 M -170 M -170 M -152 M -152 M -152 M -152 M -144 M -144 M -144 M -144 M -133 M -133 M -133 M -133 M -124 M -124 M -124 M -124 M -106 M -106 M - - - - - - - - - -

Total Assets

47.1 M 53.3 M 47.6 M 52.4 M 57.5 M 63.2 M 62.3 M - 83.3 M 89.5 M 95.1 M 98.2 M 87.5 M 90 M 90 M 90 M 90 M 27.4 M 27.4 M 27.4 M 27.4 M 34.2 M 34.2 M 34.2 M 34.2 M 24.1 M 24.1 M 24.1 M 24.1 M 9.69 M 9.69 M 9.69 M 9.69 M 11.3 M 11.3 M 11.3 M 11.3 M 8.47 M 8.47 M 8.47 M 8.47 M 4.05 M 4.05 M 4.05 M 4.05 M 3.34 M 3.34 M 3.34 M 3.34 M 2.12 M 2.12 M 2.12 M 2.12 M

Cash and Cash Equivalents

8.61 M 14.1 M 8.36 M 13.2 M 20.7 M 22.1 M 24.2 M 31.9 M 44.7 M 52.1 M 61 M 65.6 M 68.5 M 71.4 M 71.4 M 71.4 M 71.4 M 12.2 M 12.2 M 12.2 M 12.2 M 22.4 M 22.4 M 22.4 M 22.4 M 17.3 M 17.3 M 17.3 M 17.3 M 5.25 M 5.25 M 5.25 M 5.25 M 5.32 M 5.32 M 5.32 M 5.32 M 3.61 M 3.61 M 3.61 M 3.61 M 2.18 M 2.18 M 2.18 M 2.18 M 1.73 M 1.73 M 1.73 M 1.73 M 1.19 M 1.19 M 1.19 M 1.19 M

Book Value

18.9 M 23.3 M 18.5 M 24.1 M 29 M 35.4 M 39.1 M - 55.4 M 62.6 M 70.6 M 74.4 M 77.3 M 79.2 M 79.2 M 79.2 M 79.2 M 3.42 M 3.42 M 3.42 M 3.42 M 16.9 M 16.9 M 16.9 M 16.9 M 10.3 M 10.3 M 10.3 M 10.3 M 1.34 M 1.34 M -474 K -474 K 8.21 M 8.21 M 8.21 M 11.3 M 8.47 M 8.47 M 8.47 M 8.47 M 981 K 980 K 1.94 M 3.05 M 1.26 M 1.26 M 1.26 M 1.26 M 318 K 318 K 318 K 318 K

Total Shareholders Equity

18.9 M 23.3 M 18.5 M 24.1 M 29 M 35.4 M 39.1 M 47.6 M 55.4 M 62.6 M 70.6 M 74.4 M 77.3 M 79.2 M 79.2 M 79.2 M 79.2 M 3.42 M 3.42 M 3.42 M 3.42 M 16.9 M 16.9 M 16.9 M 16.9 M 10.3 M 10.3 M 10.3 M 10.3 M 1.34 M 1.34 M -474 K -474 K 9.85 M 8.21 M 8.21 M 8.21 M 6.94 M 3.96 M 3.96 M 3.96 M -14.3 M -14.3 M -14.3 M -14.3 M -11.6 M -11.6 M -11.6 M -11.6 M -10.1 M 318 K 318 K 318 K

All numbers in USD currency